Delivery Order SPE2DB22D1017-SPE2DB25FYRFW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,572.33 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. XULANE is a combination hormonal contraceptive patch used for birth...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.00 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Xulane is a combination hormonal contraceptive patch used for birth control and is...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.36 for Xulane 150-35 mcg/day transdermal patches (3-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award conditions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $10,516.82 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (3-pack) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract requires delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among eligible contractors in the open market. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $3,793.09 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit supply) on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive delivery order was placed under firm fixed pricing terms and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.20 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3) with a firm fixed price structure. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a $2,791.51 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packages) on September 8, 2025, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract performed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a small-value transaction typical of routine pharmaceutical procurement supporting military and federal healthcare systems....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRFWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,350.31 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (3-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xulane is a transdermal contraceptive patch used in military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999.99 million and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's portfolio with the DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, demonstrating its capability to meet diverse federal healthcare supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/18/25 |